Octagon Capital Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-655,051
| Closed | -$28.5M | – | 47 |
|
|
2023
Q3 | $28.5M | Sell |
655,051
-94,949
| -13% | -$4.14M | 4.38% | 7 |
|
|
2023
Q2 | $27.1M | Hold |
750,000
| – | – | 3.77% | 6 |
|
|
2023
Q1 | $27.9M | Hold |
750,000
| – | – | 4.01% | 8 |
|
|
2022
Q4 | $34M | Buy |
750,000
+529,000
| +239% | +$24M | 5.29% | 5 |
|
|
2022
Q3 | $15.4M | Buy |
+221,000
| New | +$15.4M | 2.66% | 9 |
|